We serve Chemical Name:7-Methoxy-1,2,3,4-tetrahydronaphthalen-2-amine CAS:4003-89-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:7-Methoxy-1,2,3,4-tetrahydronaphthalen-2-amine
CAS.NO:4003-89-8
Synonyms:7-Methoxycoumarin;MFCD06739168
Molecular Formula:C10H8O3
Molecular Weight:176.16900
HS Code:
Physical and Chemical Properties:
Melting point:218-220℃
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:39.44000
Exact Mass:176.04700
LogP:1.80160
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 7-Methoxycoumarin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD06739168 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,7-Methoxycoumarin Use and application,MFCD06739168 technical grade,usp/ep/jp grade.
Related News: The program will run alongside our ongoing Phase 3 INSPIRE Trial, and is expected to continue until commercial launch in such countries. 7-Methoxy-1,2,3,4-tetrahydronaphthalen-2-amine manufacturer First up is Lilly, which reached all-time highs this week as attention turned to its once highly hyped donanemab, another anti-amyloid that saw a mixed bag of data back in March, with a slight win on one disease scale undermined by a failure on a more widely used measure of Alzheimer’s. 7-Methoxy-1,2,3,4-tetrahydronaphthalen-2-amine supplier The program will run alongside our ongoing Phase 3 INSPIRE Trial, and is expected to continue until commercial launch in such countries. 7-Methoxy-1,2,3,4-tetrahydronaphthalen-2-amine vendor ��We believe such actions are our last resort,�� the Hospital Authority Employees Alliance, a union that formed during the city��s antigovernment protest movement, wrote in a statement. 7-Methoxy-1,2,3,4-tetrahydronaphthalen-2-amine factory The program will run alongside our ongoing Phase 3 INSPIRE Trial, and is expected to continue until commercial launch in such countries.